English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Tuesday, May 19, 2020
中国生物制药与康方生物共同开发派安普利单抗联合安罗替尼一线治疗晚期肝癌的临床试验数据获ASCO年会接受呈列
Results from Clinical Trials of Penpulimab in Combination with Anlotinib for 1L HCC Co-developed by Sino Biopharmaceutical and Akeso Accepted for Presentation at ASCO Annual Meeting
中國生物製藥與康方生物共同開發派安普利單抗聯合安羅替尼一線治療晚期肝癌的臨床試驗數據獲ASCO年會接受呈列
Monday, March 30, 2020
Sino Biopharm Announces 2019 Annual Results
中国生物制药公布2019年年度业绩
中國生物製藥公佈2019年年度業績
Tuesday, January 21, 2020
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
Tuesday, November 26, 2019
中国生物制药公布2019年第三季度业绩
中國生物製藥公佈2019年第三季度業績
Sino Biopharmaceutical Announces 2019 Third Quarterly Results

Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575